Biotech Bearish Stocks: Zalicus Inc (NASDAQ:ZLCS), Stemline Therapeutics Inc (NASDAQ:STML), Agenus Inc (NASDAQ:AGEN), Arrowhead Research Corp (NASDAQ:ARWR), Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)

Zalicus Inc (NASDAQ:ZLCS) on June 18 announced that it has licensed its Sodium Channel Modulator program, including intellectual property and related pipeline assets, to AnaBios Corporation in exchange for clinical milestone payments and royalties on potential future sales. Under the terms of the agreement Zalicus will be eligible to receive up to $17.2 million in clinical and regulatory milestone payments and up to 12% of … Continue reading Biotech Bearish Stocks: Zalicus Inc (NASDAQ:ZLCS), Stemline Therapeutics Inc (NASDAQ:STML), Agenus Inc (NASDAQ:AGEN), Arrowhead Research Corp (NASDAQ:ARWR), Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)

Biotech Volatile Stocks: NewLink Genetics Corp (NASDAQ:NLNK), Alnylam Pharmaceuticals (NASDAQ:ALNY), Kindred Biosciences (NASDAQ:KIN), Agenus (NASDAQ:AGEN)

NewLink Genetics Corp (NASDAQ:NLNK)’s algenpantucel-L is expected to garner the highest sales and will be launched in both resectable and unresectable locally-advanced settings. Other drugs with significant forecast sales by 2017 include Threshold Pharmaceuticals/Merck’s TH-302 and Merrimack Pharmaceuticals’ MM-398,” director says. NewLink Genetics Corp (NASDAQ:NLNK) stock performance was -9.03% in last session and finished the day at $24.98. Traded volume was 808,573.00million shares in the … Continue reading Biotech Volatile Stocks: NewLink Genetics Corp (NASDAQ:NLNK), Alnylam Pharmaceuticals (NASDAQ:ALNY), Kindred Biosciences (NASDAQ:KIN), Agenus (NASDAQ:AGEN)

Shares of Agenus Inc (NASDAQ:AGEN) , a biopharmaceutical company focused on developing novel immunotherapies to treat cancer and a number of other unmet diseases, tumbled by as much as 22% after partner GlaxoSmithKline (NYSE: GSK ) announced that its phase 3 MAGE-A3 cancer immunotherapeutic trial in non-small cell lung cancer (NSCLC) patients didn’t meet its first or second coprimary endpoint. Agenus Inc (NASDAQ:AGEN) stock performance … Continue reading Biotech Losers: Agenus Inc (NASDAQ:AGEN), La Jolla Pharmaceutical Company (NASDAQ:LJPC), Durata Therapeutics (NASDAQ:DRTX), Galmed Pharmaceuticals (NASDAQ:GLMD)

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) on Feb. 25 reported financial results for the fourth quarter and full year ended December 31, 2013 and provided an update on corporate developments. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock performance was 8.79% in last session and finished the day at $8.17. Traded volume was 18.32 million shares in the last session and the average volume of the stock remained 16.55 million … Continue reading Biotech Top Gainer: Ariad Pharmaceuticals (NASDAQ:ARIA), CEL-SCI Corporation (NYSEMKT:CVM), Synthetic Biologics (NYSEMKT:SYN), Agenus Inc. (NASDAQ:AGEN)

Agenus Inc. (NASDAQ:AGEN) will release its fourth quarter and year end 2013 financial results before the market opens on March 5, 2014. Agenus Inc. (NASDAQ:AGEN) stock performance was 0.00% in last session and finished the day at $4.89. Traded volume was 0.00 shares in the last session and the average volume of the stock remained 1.12 million shares. The beta of the stock remained 1.33. … Continue reading Biotech Overbought Stocks: Agenus Inc. (NASDAQ:AGEN), Biota Pharmaceuticals (NASDAQ:BOTA), Albany Molecular Research (NASDAQ:AMRI), Sunesis Pharmaceuticals (NASDAQ:SNSS)

3D Systems Corporation (NYSE:DDD) recently reported that it has signed a definitive agreement to acquire one of the leading CAD/CAM software solutions providers, Cimatron Ltd. (CIMT). The news was received warmly by investors as the stock rose nearly 6.7% in yesterday’s session. The transaction, valued at about $97 million or $8.97 per Cimatron’s share, is likely to be closed by the first quarter of 2015. … Continue reading Hot News: 3D Systems Corporation (NYSE:DDD), Rite Aid Corporation (NYSE:RAD), Hanesbrands Inc. (NYSE:HBI), Agenus Inc. (NASDAQ:AGEN), SunEdison, Inc. (NYSE:SUNE)